Raphael Pharmaceutical Inc. (RAPH)

OTCMKTS · Delayed Price · Currency is USD

1.400

0.00 (0.00%)

At close: Jul 28, 2026

Raphael Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0	0.05	0.02	0.23	0.29	0.15
Cash & Short-Term Investments	0	0.05	0.02	0.23	0.29	0.15
Cash Growth	-98.00%	136.84%	-91.74%	-20.14%	88.23%	61.05%
Other Receivables	-	0	0	0.01	0.04	0.09
Receivables	-	0	0	0.01	0.04	0.09
Prepaid Expenses	-	0	0	-	0.01	0.18
Total Current Assets	0	0.05	0.03	0.24	0.33	0.42
Property, Plant & Equipment	0	0	0	0	0	-
Total Assets	0	0.05	0.03	0.24	0.33	0.42

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.53	0.16	0.13	0.07	0.07	0.11
Accrued Expenses	1.1	1.29	0.6	0.06	0.16	0.19
Short-Term Debt	0.04	0.03	0.04	-	-	-
Total Current Liabilities	1.67	1.49	0.77	0.13	0.23	0.29
Total Liabilities	1.67	1.49	0.77	0.13	0.23	0.29

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.2	0.2	0.19	0.19	0.16	0.13
Additional Paid-In Capital	8.53	8.53	7.96	7.39	5.98	2.67
Retained Earnings	-10.4	-10.17	-8.89	-7.37	-6.03	-2.67
Comprehensive Income & Other	-	-	-	-0.1	-	-
Shareholders' Equity	-1.66	-1.43	-0.74	0.11	0.11	0.13
Total Liabilities & Equity	0	0.05	0.03	0.24	0.33	0.42

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.04	0.03	0.04	-	-	-
Net Cash (Debt)	-0.04	0.01	-0.02	0.23	0.29	0.15
Net Cash Growth	-	-	-	-20.14%	88.23%	-
Net Cash Per Share	-0.00	0.00	-0.00	0.01	0.02	0.01
Filing Date Shares Outstanding	20.18	20.18	19.63	18.66	16.14	12.97
Total Common Shares Outstanding	20.18	20.18	18.7	18.5	15.62	12.97
Working Capital	-1.66	-1.44	-0.74	0.11	0.1	0.13
Book Value Per Share	-0.08	-0.07	-0.04	0.01	0.01	0.01
Tangible Book Value	-1.66	-1.43	-0.74	0.11	0.11	0.13
Tangible Book Value Per Share	-0.08	-0.07	-0.04	0.01	0.01	0.01